Stroke prevention in patients with atrial fibrillation (AF) is one pillar of the management of
this common arrhythmia. Substantial advances in the epidemiology and associated …

To date, mortality rates associated with heart diseases are dangerously increasing, making
them the leading cause of death globally. From this point of view, digital technologies can …

BACKGROUND: There is ambiguity whether frail patients with atrial fibrillation managed with
vitamin K antagonists (VKAs) should be switched to a non–vitamin K oral anticoagulant …

Aims Cardiac pacing represents a key element in the field of electrophysiology and the
treatment of conduction diseases. Since the first issue published in 1999, EP Europace has …

ABSTRACT Introduction Oral anticoagulants (OACs) are the cornerstone of stroke
prevention in atrial fibrillation (AF), but prescribing decisions in older people are …

Outcomes and readmissions in patients with cancer undergoing catheter ablation for atrial
fibrillation | EP Europace | Oxford Academic Skip to Main Content Advertisement intended for …

Introduction In a large nationwide administrative database including∼ 35% of Italian
population, we analyzed the impact of oral anticoagulant treatment (OAT) in patients with a …

Background Familial hypercholesterolemia (FH) is associated with atherosclerotic
cardiovascular disease (ASCVD). However, the prevalence of FH among a general …

Introduction Atrial fibrillation (AF) cannot be considered an isolated disease. Patients with AF
should be managed using a comprehensive approach that is not limited to stroke …

BACKGROUND It remains unclear if remnant cholesterol is associated with atherosclerotic
cardiovascular disease (ASCVD)(myocardial infarction, angina pectoris and stroke), heart …